Clinical Trial Update: Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update investigating toripalimab in combination with rituximab followed by R-CHOP for elderly patients with untreated diffuse large B-cell lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• High-grade B-cell Lymphoma

Drugs mentioned

• R-CHOP
• Rituximab (rituximab)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Huiqiang Huang | Conditions: Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN